Eisenstein, M.(2019). Taking a New Shot at Tumor Vaccines : Whether they follow personalized or off-the-shelf strategies, developers are optimistic about targeting antigens unique to aberrant cells: Whether they follow personalized or off-the-shelf strategies, developers are optimistic about targeting antigens unique to aberrant cells. Genetic Engineering & Biotechnology News, 39(S1), S4-S5, S26. doi:10.1089/gen.39.s1.02